Aromatic-dependent "Salmonella sp." as live vaccine in mice and calves
- PMID: 6307785
Aromatic-dependent "Salmonella sp." as live vaccine in mice and calves
Abstract
A block in the common aromatic biosynthesis (aro) pathway makes E. coli, Salmonella, etc., exacting for aromatic metabolites; two of these, paraaminobenzoic acid and dihydroxybenzoic acid, are not mammalian metabolites. Bacteria needing substances not available in host tissues should be unable to grow there and so be non-virulent. Transposon-generated deletion and deletion-inversion mutations at aroA caused loss of mouse virulence in Salmonella typhimurium; e.g., LD50, intraperitoneal route, increased from less than 10 to greater than 10(6), and LD50 by feeding increased from ca. 10(5) to greater than 10(8). Furthermore, a single injection of 10(5) live aro- bacteria protected mice of a Salmonella-susceptible line, BALB/c, against challenge, 4 weeks later, with 5 X 10(5) virulent S. typhimurium (i.e., greater than 10(4) LD50); a single dose of the live-vaccine strain given i.p. also protected against challenge one month later by feeding 2 X 10(7) of a virulent strain. Mice vaccinated by feeding 2 X 10(8) live aro- bacteria were unaffected by feeding, one month later, 2 X 10(7) of a virulent S. typhimurium strain ( = ca 100 LD50). Intravenous injection of microparticulate silica did not reduce the mouse i.p. LD50 of an aro- strain, and 3 i.p. injections of cyclophosphamide, 4 mgm, caused only a small reduction. Thus the reduced virulence of the aro- strain does much depend on the integrity of host cellular defense mechanisms. Non-reverting aro- derivatives made from proven calf-virulent S. typhimurium and S. dublin strains are being tested at the School of Veterinary Medicine, University of California at Davis. None of 26 calves given aro- live-vaccine bacteria intramuscularly (usually 10(9)) and none of 8 calves fed ca. 10(11) live aro- bacteria, died or became seriously ill. Vaccinated and control calves were challenged by feeding 10(11) bacteria of a virulent strain, S. typhimurium or S. dublin. This challenge caused death of 14 of 16 non-vaccinated calves. The results, to date, in vaccinated animals indicate that one aro- strain of each of the two Salmonella species is effective if given as a live vaccine in two intramuscular doses.
Similar articles
-
Aromatic-dependent Salmonella typhimurium as modified live vaccines for calves.Am J Vet Res. 1984 Jan;45(1):59-66. Am J Vet Res. 1984. PMID: 6367561
-
Aromatic-dependent Salmonella dublin as a parenteral modified live vaccine for calves.Am J Vet Res. 1984 Nov;45(11):2231-5. Am J Vet Res. 1984. PMID: 6395725
-
Vaccination of calves against Salmonella dublin with aromatic-dependent Salmonella typhimurium.Am J Vet Res. 1984 Sep;45(9):1858-61. Am J Vet Res. 1984. PMID: 6388442
-
The use of live attenuated Salmonella for oral vaccination.Dev Biol Stand. 1994;82:35-42. Dev Biol Stand. 1994. PMID: 7958481 Review.
-
Immunity to Salmonella infections.J S Afr Vet Assoc. 1976 Jun;47(2):89-91. J S Afr Vet Assoc. 1976. PMID: 781241 Review.
Cited by
-
Vaccination of calves with a diaminopimelic acid mutant of Salmonella typhimurium.Can J Vet Res. 1987 Jan;51(1):32-8. Can J Vet Res. 1987. PMID: 3032389 Free PMC article.
-
Galactose epimeraseless mutants of Salmonella typhimurium as live vaccines for calves.Can J Vet Res. 1986 Apr;50(2):165-73. Can J Vet Res. 1986. PMID: 3530414 Free PMC article.
-
Comparison of the safety and immunogenicity of delta aroC delta aroD and delta cya delta crp Salmonella typhi strains in adult volunteers.Infect Immun. 1992 Feb;60(2):536-41. doi: 10.1128/iai.60.2.536-541.1992. Infect Immun. 1992. PMID: 1730487 Free PMC article. Clinical Trial.
-
Contribution of Salmonella typhimurium virulence factors to diarrheal disease in calves.Infect Immun. 1999 Sep;67(9):4879-85. doi: 10.1128/IAI.67.9.4879-4885.1999. Infect Immun. 1999. PMID: 10456944 Free PMC article.
-
Ability of SPI2 mutant of S. typhi to effectively induce antibody responses to the mucosal antigen enterotoxigenic E. coli heat labile toxin B subunit after oral delivery to humans.Vaccine. 2007 May 22;25(21):4175-82. doi: 10.1016/j.vaccine.2007.03.007. Epub 2007 Mar 21. Vaccine. 2007. PMID: 17412462 Free PMC article. Clinical Trial.